LSV Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.44M | Sell |
896,700
-4,300
| -0.5% | -$44.5K | 0.02% | 426 |
|
|
2025
Q4 | $11.1M | Buy |
901,000
+36,500
| +4% | +$391K | 0.02% | 373 |
|
|
2025
Q3 | $7.63M | Buy |
864,500
+48,909
| +6% | +$380K | 0.02% | 431 |
|
|
2025
Q2 | $5.2M | Sell |
815,591
-15,600
| -2% | -$89.3K | 0.01% | 465 |
|
|
2025
Q1 | $4.04M | Buy |
831,191
+809,591
| +3,748% | +$6.7M | 0.01% | 500 |
|
|
2024
Q4 | $206K | Buy |
+21,600
| New | +$198K | ﹤0.01% | 749 |
|
|
2023
Q3 | – | Sell |
-40,700
| Closed | -$299K | – | 867 |
|
|
2023
Q2 | $299K | Sell |
40,700
-30,576
| -43% | -$284K | ﹤0.01% | 796 |
|
|
2023
Q1 | $738K | Sell |
71,276
-34,400
| -33% | -$416K | ﹤0.01% | 689 |
|
|
2022
Q4 | $1.25M | Hold |
105,676
| – | – | ﹤0.01% | 635 |
|
|
2022
Q3 | $2.22M | Hold |
105,676
| – | – | 0.01% | 586 |
|
|
2022
Q2 | $3.28M | Hold |
105,676
| – | – | 0.01% | 561 |
|
|
2022
Q1 | $4.34M | Buy |
105,676
+14,200
| +16% | +$626K | 0.01% | 545 |
|
|
2021
Q4 | $3.98M | Buy |
91,476
+61,176
| +202% | +$2.77M | 0.01% | 570 |
|
|
2021
Q3 | $1.52M | Hold |
30,300
| – | – | ﹤0.01% | 670 |
|
|
2021
Q2 | $1.91M | Hold |
30,300
| – | – | ﹤0.01% | 651 |
|
|
2021
Q1 | $2.81M | Sell |
30,300
-2,700
| -8% | -$277K | ﹤0.01% | 635 |
|
|
2020
Q4 | $2.96M | Buy |
33,000
+7,100
| +27% | +$652K | 0.01% | 636 |
|
|
2020
Q3 | $2.68M | Hold |
25,900
| – | – | 0.01% | 624 |
|
|
2020
Q2 | $2.05M | Sell |
25,900
-4,600
| -15% | -$343K | ﹤0.01% | 666 |
|
|
2020
Q1 | $1.76M | Buy |
+30,500
| New | +$1.76M | ﹤0.01% | 659 |
|
|
2018
Q4 | – | Sell |
-17,700
| Closed | -$1.17M | – | 977 |
|
|
2018
Q3 | $1.17M | Sell |
17,700
-53,700
| -75% | -$3.13M | ﹤0.01% | 794 |
|
|
2018
Q2 | $3.6M | Sell |
71,400
-144,200
| -67% | -$7.51M | 0.01% | 661 |
|
|
2018
Q1 | $11.4M | Sell |
215,600
-530,918
| -71% | -$26.5M | 0.02% | 463 |
|
|
2017
Q4 | $34.7M | Buy |
746,518
+90,971
| +14% | +$3.83M | 0.05% | 291 |
|
|
2017
Q3 | $26.5M | Buy |
655,547
+20,832
| +3% | +$754K | 0.04% | 318 |
|
|
2017
Q2 | $21.5M | Buy |
634,715
+12,000
| +2% | +$370K | 0.04% | 348 |
|
|
2017
Q1 | $18.1M | Buy |
622,715
+78,500
| +14% | +$2.39M | 0.03% | 364 |
|
|
2016
Q4 | $17.9M | Buy |
544,215
+159,680
| +42% | +$4.79M | 0.03% | 369 |
|
|
2016
Q3 | $12.1M | Buy |
384,535
+82,500
| +27% | +$2.4M | 0.02% | 405 |
|
|
2016
Q2 | $8.49M | Buy |
302,035
+90,038
| +42% | +$3.53M | 0.02% | 450 |
|
|
2016
Q1 | $7.71M | Sell |
211,997
-98,500
| -32% | -$3.48M | 0.02% | 449 |
|
|
2015
Q4 | $12.4M | Buy |
310,497
+125,017
| +67% | +$4.36M | 0.03% | 349 |
|
|
2015
Q3 | $5.28M | Buy |
185,480
+6,878
| +4% | +$227K | 0.01% | 479 |
|
|
2015
Q2 | $5.88M | Buy |
178,602
+60,936
| +52% | +$1.89M | 0.01% | 464 |
|
|
2015
Q1 | $3.38M | Sell |
117,666
-95,409
| -45% | -$2.74M | 0.01% | 539 |
|
|
2014
Q4 | $5.8M | Buy |
213,075
+208,175
| +4,248% | +$4.96M | 0.01% | 444 |
|
|
2014
Q3 | $104K | Hold |
4,900
| – | – | ﹤0.01% | 849 |
|
|
2014
Q2 | $110K | Buy |
+4,900
| New | +$114K | ﹤0.01% | 821 |
|
Other funds holding EBS
VCM
PCM
VPM